NEMCASGO

Alkermes Pharma Ireland Limited

Application Filed: 2023-10-05

Trademark Application Details

Status

630

Live/Pending

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

Research	OneLook Acronym Finder
Serial Number	98210397
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic Representative	Norm J. Rich
Attorney Name	Norm J. Rich
Attorney Docket Number	029318-2997

Timeline

2023-10-05	Application Filed
2023-10-09	Location: NEW APPLICATION PROCESSING
2023-10-09	Status: Live/Pending
2023-10-09	Transaction Date

Trademark Applicants & Owners

Owner:	Alkermes Pharma Ireland Limited
Address	Connaught House, 1 Burlington Road Dublin 4 IE
Legal Entity Type	Corporation
Legal Entity State	IE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

NORM J. RICH
FOLEY & LARDNER LLP
3000 K STREET, N.W.
SIXTH FLOOR
WASHINGTON, DC 20007

Good, Services, and Codes

International Codes:	1
U.S. Codes:	001,005,006,010,026,046
International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052
International Codes:	42
U.S. Codes:	100,101
International Codes:	44
U.S. Codes:	100,101

Type Code	Type
GS0051	Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; therapeutic proteins for use in the manufacture of pharmaceutical preparations; Engineered fusion proteins for medical diagnostic and treatment purposes, namely fusion proteins created through the use of circular permutation technology, engineered interleukins for optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality and tumor-targeted immunotherapeutic fusion proteins; Cytokine and protein based treatments for oncology-related diseases and disorders; Cytokine and protein fusions medicines having enhanced pharmacokinetics for cancer immunotherapy research and development

Type Code

Type

GS0051

Biopharmaceutical active substances, namely, pharmaceutical preparations and substances for the treatment of oncological-related diseases and disorders; Biological preparations for the treatment of cancer; therapeutic proteins for use in the manufacture of pharmaceutical preparations; Engineered fusion proteins for medical diagnostic and treatment purposes, namely fusion proteins created through the use of circular permutation technology, engineered interleukins for optimizing patients' immune cellular response to prevent cancer-associated morbidity and mortality and tumor-targeted immunotherapeutic fusion proteins; Cytokine and protein based treatments for oncology-related diseases and disorders; Cytokine and protein fusions medicines having enhanced pharmacokinetics for cancer immunotherapy research and development

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED	2023-10-09	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	2023-10-13	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2024-01-23	3 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN	2024-01-24	4 CNRT R:Renewal
NON-FINAL ACTION E-MAILED	2024-01-24	5 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2024-01-24	6 GNRN O:Outgoing Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2024-02-28	7 ASGN I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2024-04-23	8 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2024-04-23	9 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED	2024-04-23	10 TEME I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.